1. NICE-BAD clinical audit on psoriasis
Audit contributors
BAD members, with some contributions from non-members
Leads
David de Berker and Catherine Smith
Audit standards source
NICE clinical guidelines for the assessment and management of psoriasis 2012 (CG153)
Completion date
3rd May 2013
Number of contributors
364 responses (4 unidentified) from 170 identifiable hospitals
Number of patients
1092 total; 1080 when broken down by region
Breakdown of the number of participants by region

2. Nursing and psychological support for psoriasis patients
2007 audit
Nursing: 80.2% (n=100)
Psychological:
41% (paed; n=93)
44% (adult; n=88)
Percentage of responses for the availability of nursing and psychological support in 170 participating hospitals.

3. Prescription of systemic agents and BADBIR entry
Percentage of responses for prescribing systemic agents and entry into BADBIR amongst 364 respondents.

4. Availability of phototherapy services
(n=170)
2007 audit
PUVA: 90% (n=96)
UVB (TL01): 92% (n=97)
Percentage of responses for the availability of PUVA and UVB services in 170 participating hospitals.

5. Phototherapy services waiting times
Percentage of responses for the average waiting times for PUVA and UVB services in 167* participating hospitals.
*Conflicting data for 3 hospitals currently still unresolved

6. Phototherapy services waiting times 2007
Percentage of responses for the average waiting times for PUVA and UVB services in 101 participating hospitals.

7. Physician’s Global Assessment
Global results
72/84
13/18
107/123
103/129
53/63
79/102
37/57
35/42
101/129
90/114
41/60
48/66
38/60
20/33
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded a PGA for each patient, per hospital in each region.

8. Psoriasis Area and Severity Index
12/18
60/129
31/60
Global results
49/66
52/63
45/84
73/102
80/129
40/57
62/123
29/42
71/114
31/60
10/33
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded a PASI scoring for each patient, per hospital in each region.

9. Dermatology Life Quality Index
12/18
58/129
25/60
82/129
Global results
50/66
51/63
63/102
28/60
37/57
64/123
28/42
66/114
41/84
12/33
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded a DLQI scoring for each patient, per hospital in each region.

10. Psoriasis Epidemiological Screening Tool
6/18
Global results
13/60
9/129
7/114
7/129
2/66
5/84
3/33
6/102
1/57
2/123
1/42
1/63
0/60
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded a PEST scoring for each patient, per hospital in each region.

11. Psoriasis Epidemiological Screening Tool
6/13
8/96
7/60
13/46
7/81
1/28
3/19
6/66
2/34
5/43
2/72
1/30
1/49
0/28
(n = 667)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded a PEST scoring for each of the 667 patients from identifiable hospitals who has been assessed for psoriatic arthritis, per hospital, in each region.

12. Involvement of nails, high-impact and difficult-to-treat sites
10/18
95/129
44/60
Global results
79/102
37/42
44/63
89/114
51/66
19/33
35/57
70/123
53/84
38/60
100/129
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded involvement of nails, high-impact and difficult-to-treat sites in assessing disease severity for each patient, per hospital in each region.

13. Systemic upset Global results (n = 1092) (n = 1080)
33/114
21/66
6/33
Global results
5/18
42/129
9/57
13/84
15/123
6/42
4/60
28/129
21/60
24/63
39/102
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded any systemic upset in assessing disease severity for each patient, per hospital in each region.

14. Assessment for psoriatic arthritis
13/18
28/60
81/129
30/42
Global results
74/123
46/60
49/63
96/129
28/57
60/114
34/66
43/84
19/33
66/102
(n = 1092)
(n = 1080)
Boxplots representing the distributional mean percentage of “Yes” responses to having recorded assessment for psoriatic arthritis for each patient, per hospital in each region.